Overview

Gender

female

Professor Jackie Hunter is the CEO of BenevolentBio. She has held senior positions at global pharmaceutical organisations including GSK, Proximagen and OI Pharma Partners and joined benevolent.ai as CEO of benevolent Bio in 2016. Jackie has a vast academic and business experience in the biomedical and pharmaceutical sectors. She directs the application of benevolent.ai’s technology for drug development and give the company the insight it needs to operate its unique business model – one which sees it not only researching, but also developing the blueprint for new drugs.